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The increasing concern about the high cost of medical care 
prompts an analysis of what we as cardiologists do, the cost 
of our doing it and, thus, the question, Does it really make a 
difference? I pose this question only as it relates to clinical 
decision making. No one can deny the importance of the 
advances in cardiovascular medicine and surgery that have 
occurred over the past several decades, but the cost of 
providing medical services has provoked a societal response 
that is transforming medical practice. 
Examining what we as cardiologists actually do as re-
flected in the Medicare data base is of great importance to 
each of us individually, to those responsible for educating 
physicians and to the ACC as a professional society. Al-
though there are obvious limitations to these data, they 
provide a perspective on our activities that contributes to the 
impression society develops about our profession. 
Expenditures for services provided by cardiologists. So 
how do we as cardiologists affect the nation's health care 
expenditures? According to the Medicare data base, in 1989, 
of the $28.6 billion in allowed charges for physician services 
under Medicare, 7.6% ($2.17 billion) went to cardiologists. 
Table 1 lists, for 1989, the seven highest ranking individual 
current procedural terminology codes for services per-
formed by cardiologists as well as total Medicare expendi-
tures for each of these services. Also listed in Table 1 are the 
number of times these seven services were performed in 
1989 with the percent change from 1986 to 1989 for both the 
volume of services performed and expenditures. 
Table 1 provides several bases for considering the ques-
tion, Does it really make a difference? First, the percent 
increase in volume of services performed far exceeds the 
estimated 2% annual increase in the number of patients 
enrolled in Medicare. 
Second, the increase in the number of self-designated 
adult cardiologists in the U.S.-from 14,157 in 1986 to 15,445 
in 1989 (1)-is unlikely to account for the increased volume 
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of services. Was there a large previously underserved Medi-
care population that gained access to care during this period? 
That is highly unlikely. It seems more probable that we are 
observing an expansion in availability and utilization of 
services. 
In addition, I suspect that important economic incentives 
are at work in some of these increases in rate of procedure 
utilization. Although many adult cardiologists do not ac-
knowledge the reality of potential self-referral bias (an 
observation based on two ACC Strategic Planning Commit-
tee surveys) other segments of the medical profession sur-
veyed believe such a conflict exists. Self-referral bias ap-
pears to be a real issue on which the College's Ethics 
Committee is providing a focus for continuing discussion. 
Each of us might have additional responses to Table 1. Mine 
include the following observations. 
Left heart catheterization with coronary angiography. Not 
surprisingly, left heart catheterization with coronary angiog-
raphy continues to rank highest among the expenditures for 
services performed by cardiologists, with a 77% increase in 
volume of procedures as compared with 1986. It would be 
helpful to know the number of new laboratories that have 
entered the data base since 1986 and the proportion of 
patients whose coronary angiographic study is a repeat study 
after coronary angioplasty or bypass surgery. The number of 
Medicare patients undergoing one or more of these proce-
dures for the first time is not clear. What proportion had 
normal coronary arteriograms? What has been the impact of 
noninvasive testing on the use of coronary arteriography? 
Coronary arteriography represents one of the major ad-
vances in cardiology and we must be vigilant to ensure that 
it is used appropriately. The ACC/AHA guidelines on coro-
nary angiography were published in the Journal in 1987 (2), 
but one might speculate that the increase in the number of 
laboratories performing coronary arteriography overwhelms 
any impact of those guidelines on decreasing rates of utili-
zation. It is noteworthy that in the 1991 ACC Strategic 
Planning Committee Survey (unpublished data), 47% of 
respondents agreed that the ACC should advocate restricting 
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Services Performed in 1989 
No. of %Change Expenditures %Change 
Service (CPT Code) Procedures 1986-1989 in 1989 $ From 1986 
Lv/Cath/Cor Angio 206,181 77 149,635,525 100 
2-D Echo, Complete 918,644 143 126,530,601 236 
Hospital Visit, Intermediate 3,413,235 43 118,716,%9 57 
ECG, Interp & Report, Only 8,252,412 53 114,628,537 74 
RV/LV Cath/Cor Angio 109,440 55 101,756,089 75 
Office Visit, Estab Interm 2,911,505 51 92,897,545 72 
PTCA, Single Artery 59,321 82 91,134,427 166 
*From the Medicare BMAD-1 Procedure Files, 1986-1989. CPT = current procedural terminology; ECG = electrocardiogram; Estab = established; 
Interm = intermediate; Interp = interpretation; LV/Cath/Cor Angio = left heart catheterization with coronary angiography; PTCA = percutaneous transluminal 
coronary angioplasty; RV/LV Cath/Cor Angio = right and left heart catheterization with coronary angiography; 2-D Echo= two-dimensional echocardiography. 
the growth in the number of cardiac catheterization labora-
tories and 49% agreed that the College should advocate 
restricting the growth in the number of mobile cardiac 
catheterization laboratories. 
Echocardiographic studies. Another remarkable finding is 
the increase in the utilization of two-dimensional echocar-
diographic studies. One must be cautious in interpreting 
these data because the coding of echocardiographic studies 
has changed. However, the 143% increase in "2-D Echo, 
Complete" seems extraordinary and raises several ques-
tions. How has the health care of our citizens been improved 
by this exceptional increase in utilization of echocardiog-
raphy over a 3-year period? What proportion of these studies 
truly influenced clinical decision making and actual out-
come? How many studies were done as part of a routine 
follow-up examination, at what intervals and for what rea-
son? As a practitioner, I confess that I share the excitement 
about the ability to clearly define cardiac structure and 
function with a noninvasive technique such as echocardiog-
raphy. Patients are also attracted to this technology and are 
fascinated to observe their own heart on a television screen. 
I suspect patient expectations also contribute to the increase 
in utilization of this technology. However, I fear that at 
times we all fail to think about what the cost of this 
marvelous technology adds to the evaluation of our patients. 
One might conclude that this trend in application of echo-
cardiography reflects a growing dependence on sophisticated 
imaging technology, even in settings where obtaining a 
thorough history, physical examination, chest X-ray film and 
electrocardiogram (ECG) may suffice for clinical decision 
making. 
The use of two-dimensional echocardiographic studies is 
an important issue for the ACC, given our major commit-
ment to the education of cardiologists. We have provided 
superb materials and programs for achieving high quality in 
performance and interpretation of these studies while en-
hancing the training of both the physicians and the sonogra-
phers responsible for them. Perhaps the recent ACC/ AHA 
guidelines for utilizing echocardiographic studies (3) will 
have an effect; if not, additional efforts may need to be made 
to influence physician behavior in applying this expensive 
but important technology. 
Percutaneous transluminal coronary angioplasty. Another 
item in Table l worth noting is the frequency of "PTCA, 
Single Artery." Obviously, it is impossible to judge the 
appropriateness of interventions performed under this code 
without having detailed clinical data. However, the numbers 
seem high when one considers data projections from the 
Coronary Artery Surgery Study (CASS) registry for percu-
taneous transluminal coronary angioplasty and single-vessel 
disease (4). Although the proportion of patients with multi-
vessel versus single-vessel disease is not clear from these 
data, I suspect that most angioplasty procedures are per-
formed in patients with single-vessel disease. Unpublished 
data (1991) from the participating centers of the Bypass 
Angioplasty Revascularization Investigation (BARI) indi-
cate that single-vessel angioplasty in the setting of single-
vessel disease accounts for approximately 25% of all revas-
cularization procedures, and represents the most common 
use of coronary angioplasty (4). Does it really make a 
difference? must be asked again. It certainly should make a 
difference for patients with severe angina associated with 
single-vessel disease, but the assumption that angioplasty is 
the best therapy for patients with single vessel disease is not 
proved, particularly for patients with proximal left anterior 
descending coronary artery disease (5). 
Does coronary angioplasty really make a difference in 
mildly symptomatic or asymptomatic patients with single-
vessel disease? There are no controlled studies to demon-
strate improved survival or reduced rates of myocardial 
infarction as a result of such an intervention, although the 
Veterans Affairs ACME trial has reported less ischemia at 6 
months follow-up after angioplasty in comparison with that 
in patients who received medical therapy (6). Even though 
the data in Table 1 are insufficient to judge the appropriate-
ness or inappropriateness of single-vessel angioplasty, as a 
profession we need to question the high utilization rates in 
this setting. New laboratories and the increased number of 
interventional cardiologists probably contribute to the high 
rates of angioplasty performed in an environment of increas-
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ing use of coronary arteriography. An unpublished 1990 
ACC membership profile indicated that 74% of all Fellows of 
the College perform invasive procedures and 43% perform 
angioplasty. The questions about self-referral bias and eco-
nomic incentives apply here as well. 
Right heart catheterization with coronary angiography. 
To me, the most astounding finding in Table 1 is the 
continuing increase in the use of right heart catheterization 
at the time of coronary angiography. This combination 
ranked fifth in overall expenditures for services performed 
by cardiologists in 1989, a ranking that seems out of propor-
tion to any clinical findings that would require a right heart 
catheterization in patients having a diagnostic coronary 
arteriogram. I have also been told of routine temporary 
pacemaker placements by some cardiologists in the setting 
of diagnostic coronary arteriography or angioplasty. Unfor-
tunately, I believe that the overwhelming proportion of these 
additional procedures are performed on the basis of eco-
nomic incentive to do so and, in most cases, the answer to 
the question, Does it really make a difference?, is no (at least 
for clinical decision making). The ACC/AHA guidelines on 
coronary angiography (2) clearly state ". . . right heart 
catheterization is not routinely part of coronary angiogra-
phy .... '' I fully agree with this conclusion. 
Finally, it is positive in my view that hospital and office 
visits rank high on the list of services provided (Table 1), 
illustrating that cardiovascular specialists perform a great 
many cognitive services, a point in need of emphasis. 
If on further study, the utilization rates are accurate and 
in part reflect inappropriate use of procedures or other 
interventions, I believe it is up to us as cardiologists to set 
our house in order. We should also defend vigorously those 
interventions that clearly do make a difference. Each of us 
should think carefully about our utilization of the extraordi-
nary array of services that we can provide our patients and 
be certain that each service is truly necessary. A challenge to 
those responsible for educating physicians is how to teach 
the added value of the new and exciting advances over and 
above existing, less glamorous, clinical approaches to prob-
lem solving. As a major contributor to continuing education, 
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the ACC must continue to strive for high quality programs 
not only to teach the new technology but also to put in 
perspective its appropriate utilization. The ACC Database 
also provides an opportunity to explore the relative contri-
bution of expanding availability of services to the high rate of 
utilization of coronary arteriography. 
In conclusion, more than ever, with respect to all of our 
diagnostic and therapeutic strategies, we must ask ourselves 
as doctors, Does it really make a difference? Although the 
increases in expenditures for services performed by cardiol-
ogists may seem small in relation to the overall expenditures 
for health care, we cannot ignore the reality of societal 
concern about these issues. Reducing utilization of one or 
another procedure clearly will not solve the overall high cost 
of medical care, but we have a professional responsibility to 
provide only those services that are truly in the best interest 
of the patient. 
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